Amir Reichman
Vermögen: 76 320 $ am 31.05.2026
Vermögen: 76 320 $ am 31.05.2026
Amir Reichman was the founder of NeuroDerm Ltd. since 2003, holding the title of Chief Engineer & Senior Scientist from 2003 to 2009.
Mr. Reichman is currently the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd. since 2021.
Former positions include Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2017 to 2021 and Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina) from 2011 to 2015.
Education includes an undergraduate degree from Ben-Gurion University of the Negev and an MBA from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.06.2026 | 67.540.000 ( 0,34 % ) | 76 320 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Vorstandsvorsitzender | 02.03.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Corporate Officer/Principal | 01.03.2021 |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01.01.2015 |
| NEURODERM LTD | Gründer | 01.01.2009 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen